Author:
Li Mengyun,Wang Zining,Xie Chunyuan,Xia Xiaojun
Reference102 articles.
1. Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial;Alberer;Lancet,2017
2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N. Engl. J. Med.,2021
3. Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection;Baeza Garcia;Nat. Commun.,2018
4. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA;Baiersdorfer;Mol. Ther. Nucleic Acids,2019
5. Abstract CT210: a phase I, open-label, multicenter, dose escalation study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral injection alone and in combination with immune checkpoint blockade;Bauer;Cancer Res.,2019
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献